Alpha Emitter Market
According to Intent Market Research, the Alpha Emitter Market is expected to grow from USD 536.5 million in 2023 at a CAGR of 13.8% to touch USD 1,323.0 million by 2030. The Alpha Emitter Market is dominated by key players such as Alpha Therapeutics, Bayer AG, AstraZeneca PLC, Eli Lilly and Co., General Electric (GE) Healthcare, Canberra Industries, Inc., Thermo Fisher Scientific, Inc., Actinium Pharmaceuticals, Curium Pharma, Lantheus Holdings, Inc., Eckert & Ziegler AG, Novartis AG, Siemens Healthineers, PharmaLogic, Ion Beam Applications.